Your Daily Synthetic Biology Briefing

AI Enables Design of New Molecules with Selective Cellular Targeting

• Researchers at IRB Barcelona have developed an AI-driven framework to design novel chemical entities that selectively target specific cell types, such as pancreatic cancer cells. This phenotypic discovery approach achieved superior success over traditional screening, yielding many structurally innovative AI-designed molecules.

  Eurekalert

• A self-driving synthetic biology lab, highlighted by the World Economic Forum, now automates the entire experimental pipeline from planning to execution. This AI integration has reduced planning-to-execution time by over 70% and increased experiment throughput per scientist by two to three-fold.

  Weforum

• Synthetic biology advancements are resolving production bottlenecks for ergothioneine, a functional raw material. These improvements have lowered costs and boosted purity, enabling its large-scale application in sectors like skincare and food.

  Lasvegassun